Insulet Reports Fourth Quarter Revenue of $130.5 Million, Up 26%, and Gross Margin Up 210 Basis Points, Exceeding Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Insulet Corporation (PODD) PT Raised to $90 at Cowen; Beat and Raise
February 22, 2018 6:55 AM ESTCowen raised its price target on Insulet Corporation (NASDAQ: PODD) to $90.00 (from $80.00) while maintaining a Outperform rating.
Analyst Doug Schenkel commented, "PODD posted another strong beat and initiated 2018 guidance well ahead of expectations at the top and bottom lines, despite lighter than expected... More
Insulet (PODD) Misses Q4 EPS by 4c, Revs Beat
February 21, 2018 4:01 PM ESTInsulet (NASDAQ: PODD) reported Q4 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $130.5 million versus the consensus estimate of $125.15 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
... More